Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Geriletu Ao"'
Publikováno v:
Immunobiology, Vol 229, Iss 5, Pp 152835- (2024)
Podocytes maintain renal filtration integrity when the glomerular filtration barrier (GFB) is integrated. Impairment or attrition of podocytes, leading to compromised GFB permeability, constitutes the primary etiology of proteinuria and is a hallmark
Externí odkaz:
https://doaj.org/article/382f7d57344549e0a2fc20bf0b610887
Autor:
Qingyang Chen, Haodong Zhou, Jiarong Tang, Yingbiao Sun, Geriletu Ao, Hongjun Zhao, Xuhong Chang
Publikováno v:
Frontiers in Public Health, Vol 12 (2024)
BackgroundSome occupational and environmental exposures could increase the risk of chronic obstructive pulmonary disease (COPD) and hypertension in various work and living environments. However, the effect of exposure to multiple exogenous harmful su
Externí odkaz:
https://doaj.org/article/4cb869b24eb3422688f01f5ca1677c76
Autor:
Ziwei Jiang, Wei Gai, Xiaojing Zhang, Yafeng Zheng, Xuru Jin, Zhiqiang Han, Geriletu Ao, Jiahuan He, Danni Shu, Xianbing Liu, Yingying Zhou, Zhidan Hua
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 14 (2024)
BackgroundInvestigations assessing the value of metagenomic next-generation sequencing (mNGS) for distinguish Aspergillus infection from colonization are currently insufficient.MethodsThe performance of mNGS in distinguishing Aspergillus infection fr
Externí odkaz:
https://doaj.org/article/a28fef468615406a8af280dfd0f7dcdb
Autor:
Runhan Liu, Valentina Boni, Ana Gomes, Emiliano Calvo, Maria de Miguel, Irene Moreno, Antonio Cubillo, Geriletu Ao, Lisardo Ugidos, José Miguel Cardenas
Publikováno v:
Investigational New Drugs. 39:1694-1701
Introduction The number of cancer cases among the elderly continue to increase as the worldwide population ages. This patient subset is underrepresented in clinical trials, partly because of unresolved uncertainties about age-associated tolerabilitie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::193a74741664af2c1bf7ba8045bc51c5
https://doi.org/10.1007/s10637-021-01150-1
https://doi.org/10.1007/s10637-021-01150-1
Autor:
Maria de Miguel, Runhan Liu, José Miguel Cárdenas Rebollo, Irene Moreno, Emiliano Calvo, Ana Gomes, Lisardo Ugidos, Geriletu Ao, Valentina Boni
Publikováno v:
Oncology. 99(7)
Introduction: Phase I trials aim to determine the maximum-tolerated dose of a particular drug while minimizing the number of patients exposed to either sub-therapeutic doses or severe toxicity. Thus, patient selection for phase I trials is a key comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a52df28ea2789411a4af574957f5b40b
https://pubmed.ncbi.nlm.nih.gov/33784674
https://pubmed.ncbi.nlm.nih.gov/33784674
Autor:
M.J. de Miguel, Runhan Liu, Valentina Boni, Lisardo Ugidos, Ana Gomes, José Miguel Cardenas, Emiliano Calvo, Antonio Cubillo, Irene Moreno, Geriletu Ao
Publikováno v:
Annals of Oncology. 31:S497
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3e17e70412df9289050bea6a7fcbeff
https://doi.org/10.1016/j.annonc.2020.08.706
https://doi.org/10.1016/j.annonc.2020.08.706
Autor:
Irene Moreno, Geriletu Ao, Ana Gomes, José Miguel Cardenas, Valentina Boni, Antonio Cubillo, Runhan Liu, M.J. de Miguel, Lisardo Ugidos, Emiliano Calvo
Publikováno v:
Annals of Oncology. 31:S495
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93b9493bc39587b2029b51450b1ecdea
https://doi.org/10.1016/j.annonc.2020.08.701
https://doi.org/10.1016/j.annonc.2020.08.701